CA AB 2489
in committeeControlled substances: research.
California · 2025-2026 Regular Session · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did CA AB 2489 pass?
Not yet. CA AB 2489 is in committee and has not come to a final vote. Latest recorded action (2026-05-14): In committee: Held under submission.
What is CA AB 2489 about?
Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 designated schedules, with the most restrictive limitations generally placed on controlled substances classified in Schedule I, and the least restrictive limitations generally placed on controlled substances in Schedule V. Existing law creates the Research Advisory Panel, as specified, to conduct hearings on, and in other ways study, research projects concerning controlled substances. Existing law authorizes the panel to approve research projects that have been registered with the Attorney General concerning the nature and effects of cannabis or hallucinogenic drugs and the treatment of abuse of controlled substances. Existing law authorizes a person who, under federal law, is entitled to use controlled substances for the purpose of research, instruction, or analysis to lawfully obtain and use those controlled substances upon approval by the panel, as specified. This bill, the California Veterans' Right to Try Act, would, until January 1, 2032, authorize the Research Advisory Panel to submit an investigational new drug application to the United States Food and Drug Administration requesting approval for a clinical trial of Schedule I or Schedule II controlled substances to study the administration and efficacy of those compounds among a patient pool comprised exclusively of veteran subjects with comorbidities that commonly overlap with the incidence of suicidality among veterans. This bill would make technical changes and would make related findings and declarations.
Who sponsors CA AB 2489?
Lowenthal is the primary sponsor of CA AB 2489, joined by 3 cosponsors.
Description
Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 designated schedules, with the most restrictive limitations generally placed on controlled substances classified in Schedule I, and the least restrictive limitations generally placed on controlled substances in Schedule V. Existing law creates the Research Advisory Panel, as specified, to conduct hearings on, and in other ways study, research projects concerning controlled substances. Existing law authorizes the panel to approve research projects that have been registered with the Attorney General concerning the nature and effects of cannabis or hallucinogenic drugs and the treatment of abuse of controlled substances. Existing law authorizes a person who, under federal law, is entitled to use controlled substances for the purpose of research, instruction, or analysis to lawfully obtain and use those controlled substances upon approval by the panel, as specified. This bill, the California Veterans' Right to Try Act, would, until January 1, 2032, authorize the Research Advisory Panel to submit an investigational new drug application to the United States Food and Drug Administration requesting approval for a clinical trial of Schedule I or Schedule II controlled substances to study the administration and efficacy of those compounds among a patient pool comprised exclusively of veteran subjects with comorbidities that commonly overlap with the incidence of suicidality among veterans. This bill would make technical changes and would make related findings and declarations.
- Introduced
- 2026-04-08
- Latest action
- 2026-05-14 — In committee: Held under submission.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Lowenthalauthor
- Jeff Gonzalezprincipal coauthor
- Harabediancoauthor
- Pattersoncoauthor
Committees
Not provided by source.
Action timeline
Newest first
2026-05-14
Coauthors revised.
2026-05-14
In committee: Held under submission.
2026-04-29
In committee: Set, first hearing. Referred to APPR. suspense file.
referral-committee
2026-04-13
Re-referred to Com. on APPR.
referral-committee
2026-04-09
Read second time and amended.
amendment-passage,reading-1,reading-2
2026-04-08
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 16. Noes 0.) (April 7).
amendment-introduction,amendment-passage,committee-passage,referral-committee
2026-03-09
Referred to Coms. on HEALTH and M. & V.A.
referral-committee
2026-02-21
From printer. May be heard in committee March 23.
2026-02-20
Read first time. To print.
reading-1
Versions
Documents
- application/pdf
- application/pdf
- text/html
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
Votes
Do pass as amended and be re-referred to the Committee on [Appropriations]
2026-04-07 · pass · 16-0
Member-level votes (16)
- Aguiar-Curry: yes
- Patterson: yes
- Rogers: yes
- Schiavo: yes
- Mark González: yes
- Stefani: yes
- Chen: yes
- Bonta: yes
- Carrillo: yes
- Sanchez: yes
- Caloza: yes
- Addis: yes
- Ahrens: yes
- Sharp-Collins: yes
- Johnson: yes
- Patel: yes
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T01:34:27.960412Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 2489. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.